EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

High Inter- and Intratumoral Variability of Ki67 Labeling Index in Newly Diagnosed Prostate Cancer with High Gleason Scores

Tatjana Vlajnic, Patrik Brunner, Serenella Eppenberger-Castori, Cyrill A Rentsch, Tobias Zellweger, Lukas Bubendorf

Pathobiology · 2022 · 89 (2) · 74-80

DOI: 10.1159/000519007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathobiology, online erschienen am 23.09.2021. Verfasst von Tatjana Vlajnic und 5 weiteren Autor:innen. Beteiligte Einrichtung: Pathology, Institute of Medical Genetics and Pathology, University Hospital Basel, University of Basel, Basel, Switzerland. Hauptthemen laut MEDLINE: Prostatic Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The majority of studies investigating the role of Ki67 labeling index (LI) in prostate carcinoma (PC) focused on localized PC treated radically, where Ki67 LI is regarded as a prognostic marker. The relevance of Ki67 in advanced PC remains largely unexplored. While Gleason score is still one of the best indicators of clinical outcomes in PC, differences in progression-free survival and overall survival in patients with high Gleason scores suggest that additional factors are involved in tumor progression. Understanding the underlying mechanisms could help to optimize treatment strategies for an individual patient. Here, we aimed to determine the inter- and intratumoral distribution of Ki67 LI in patients with PC with high Gleason scores and to correlate Ki67 LI with the status of ERG, PTEN, and Bcl-2.

Methods

Immunohistochemistry for Ki67, ERG, PTEN, and Bcl-2 was performed on core needle biopsies from 112 patients with newly diagnosed PC Gleason score 8, 9, and 10.

Results

Using a cutoff of ≥10%, 17/112 cases (15%) had a homogeneously low and 95/112 cases (85%) a high Ki67 LI. 41% of cases showed intratumoral heterogeneity containing areas with low and high proliferation. There was no association between Ki67 LI and ERG, PTEN, or Bcl-2 status.

Conclusions

Our data demonstrate major inter- and intratumoral variability of Ki67 LI in high-grade PC with a surprisingly low Ki67 LI in a subset of cases. Further studies are necessary to explore the molecular basis and potential clinical implications of a paradoxically low proliferation rate in high-grade PC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsBiomarkers, TumorBiopsy, Large-Core NeedleHumansImmunohistochemistryKi-67 AntigenMaleNeoplasm Grading

Stichwörter der Autor:innen

Ki67ProliferationProstate cancer

Substanzen

Biomarkers, TumorKi-67 Antigen

Autor:innen und Institutionen

  • Pathology, Institute of Medical Genetics and Pathology, University Hospital Basel, University of Basel, Basel, Switzerland.
  • Department of Urology, University Hospital Basel, Basel, Switzerland.
  • Division of Urology, St. Clara Hospital, Basel, Switzerland.

Zitieren

APA

Vlajnic, T., Brunner, P., Eppenberger-Castori, S., Rentsch, C. A., Zellweger, T., & Bubendorf, L. (2022). High Inter- and Intratumoral Variability of Ki67 Labeling Index in Newly Diagnosed Prostate Cancer with High Gleason Scores. Pathobiology, 89(2), 74-80. https://doi.org/10.1159/000519007

Vancouver

Vlajnic T, Brunner P, Eppenberger-Castori S, Rentsch CA, Zellweger T, Bubendorf L. High Inter- and Intratumoral Variability of Ki67 Labeling Index in Newly Diagnosed Prostate Cancer with High Gleason Scores. Pathobiology. 2022;89(2):74-80. doi:10.1159/000519007

BibTeX
@article{Vlajnic2022,
  author = {Vlajnic, Tatjana and Brunner, Patrik and Eppenberger-Castori, Serenella and Rentsch, Cyrill A and Zellweger, Tobias and Bubendorf, Lukas},
  title = {High Inter- and Intratumoral Variability of Ki67 Labeling Index in Newly Diagnosed Prostate Cancer with High Gleason Scores},
  journal = {Pathobiology},
  year = {2022},
  volume = {89},
  number = {2},
  pages = {74--80},
  doi = {10.1159/000519007}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche